Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Dividends Paid - Common (2022 - 2025)

Iradimed (IRMD) has disclosed Dividends Paid - Common for 4 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • Quarterly Dividends Paid - Common rose 350.02% to $8.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Dec 2025, up 9.97% year-over-year, with the annual reading at $15.0 million for FY2025, 9.97% up from the prior year.
  • Dividends Paid - Common for Q4 2025 was $8.6 million at Iradimed, up from $2.2 million in the prior quarter.
  • The five-year high for Dividends Paid - Common was $13.2 million in Q1 2023, with the low at $1.9 million in Q2 2024.
  • Average Dividends Paid - Common over 4 years is $5.4 million, with a median of $2.2 million recorded in 2025.
  • Peak annual rise in Dividends Paid - Common hit 350.02% in 2025, while the deepest fall reached 72.9% in 2025.
  • Over 4 years, Dividends Paid - Common stood at $12.6 million in 2022, then increased by 5.29% to $13.2 million in 2023, then crashed by 85.62% to $1.9 million in 2024, then soared by 350.02% to $8.6 million in 2025.
  • According to Business Quant data, Dividends Paid - Common over the past three periods came in at $8.6 million, $2.2 million, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.